-+ 0.00%
-+ 0.00%
-+ 0.00%

PALVELLA THERAPEUTICS INC - PLANS PHASE 2 TRIAL FOR QTORIN RAPAMYCIN IN H2 2026

Reuters·12/16/2025 12:30:00

Please log in to view news